Monoclonal Antibodies for the Prevention and Treatment of COVID-19 Disease in Patients With Hematological Malignancies: Two Case Reports and a Literature Review

被引：3
|
作者：
Klank, David [1 ]
Hoffmann, Martin [1 ]
Claus, Bernd [1 ]
Zinke, Florian [1 ]
Bergner, Raoul [1 ]
Paschka, Peter [1 ]
机构：
[1] Hosp Ludwigshafen, Med Clin, Ludwigshafen, Germany
来源：
HEMASPHERE | 2021年 / 5卷 / 11期
关键词：
D O I：
10.1097/HS9.0000000000000651
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Treatment approaches for managing patients with hematological malignancies in the time of COVID-19 pandemic
    Cengiz Seval, Guldane
    Topcuoglu, Pervin
    Demirer, Taner
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (06) : 2799 - 2809
  • [22] Monoclonal Antibodies in Prevention and Early Treatment of COVID-19 in Lung Transplant Recipients: A Systematic Review and Perspective on the Role of Monoclonal Antibodies in the Future
    Van Eijndhoven, David A.
    Vos, Robin
    Bos, Saskia
    TRANSPLANT INTERNATIONAL, 2025, 38
  • [23] SYSTEMATIC REVIEW OF MONOCLONAL ANTIBODIES AS TREATMENT FOR COVID-19 DURING PREGNANCY
    Bugaighis, Mona
    Milosh, Brooke C.
    Herman, Saori Wendy
    Olvet, Doreen
    Cervia, Joseph
    JOURNAL OF INVESTIGATIVE MEDICINE, 2023, 71 (06)
  • [24] Neutralizing monoclonal antibodies for treatment of COVID-19
    Taylor, Peter C.
    Adams, Andrew C.
    Hufford, Matthew M.
    de la Torre, Inmaculada
    Winthrop, Kevin
    Gottlieb, Robert L.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (06) : 382 - 393
  • [25] Neutralizing monoclonal antibodies for treatment of COVID-19
    Peter C. Taylor
    Andrew C. Adams
    Matthew M. Hufford
    Inmaculada de la Torre
    Kevin Winthrop
    Robert L. Gottlieb
    Nature Reviews Immunology, 2021, 21 : 382 - 393
  • [26] The Relevance of Monoclonal Antibodies in the Treatment of COVID-19
    Torrente-Lopez, Anabel
    Hermosilla, Jesus
    Navas, Natalia
    Cuadros-Rodriguez, Luis
    Cabeza, Jose
    Salmeron-Garcia, Antonio
    VACCINES, 2021, 9 (06)
  • [27] Prevention of COVID-19 development in patients with hematological pathology receiving monoclonal antibody therapy
    Ignateva, E.
    Rukavitsyn, O.
    Kazakov, S.
    CLINICA CHIMICA ACTA, 2024, 558
  • [28] Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
    Vita, Serena
    Rosati, Silvia
    Ascoli Bartoli, Tommaso
    Beccacece, Alessia
    D'Abramo, Alessandra
    Mariano, Andrea
    Scorzolini, Laura
    Goletti, Delia
    Nicastri, Emanuele
    PATHOGENS, 2022, 11 (08):
  • [29] The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19
    Nishikubo, Masashi
    Shimomura, Yoshimitsu
    Nagai, Yuya
    Kondo, Tadakazu
    Ishikawa, Takayuki
    BLOOD, 2022, 140 : 11195 - 11196
  • [30] Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review
    Shonai, Takuto
    Kimura, Fumihiko
    Watanabe, Junichi
    INTERNAL MEDICINE, 2022, 61 (10) : 1581 - 1585
12345